The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(2-(benzo[d]oxazol-2-ylamino)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyrimidine-5-carboxamido)nicotinicacid ID: ALA5076512
PubChem CID: 156899017
Max Phase: Preclinical
Molecular Formula: C25H19ClN6O4
Molecular Weight: 502.92
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC1=C(C(=O)Nc2cncc(C(=O)O)c2)C(c2ccccc2Cl)N=C(Nc2nc3ccccc3o2)N1
Standard InChI: InChI=1S/C25H19ClN6O4/c1-13-20(22(33)29-15-10-14(23(34)35)11-27-12-15)21(16-6-2-3-7-17(16)26)31-24(28-13)32-25-30-18-8-4-5-9-19(18)36-25/h2-12,21H,1H3,(H,29,33)(H,34,35)(H2,28,30,31,32)
Standard InChI Key: JTQMHQQHIGQUSQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
42.1694 -13.5343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1559 -14.1195 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
42.1694 -12.3594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1828 -11.7747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1924 -12.3588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1924 -13.5290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1853 -14.1130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1853 -15.2834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1988 -15.8685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2123 -15.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.2257 -15.8685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
47.2392 -15.2834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.2396 -14.1131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.2507 -13.5307 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
49.2644 -14.1161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
49.2666 -15.2805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.2570 -15.8711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
50.2800 -15.8657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
51.2935 -15.2805 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
50.2800 -17.0359 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
45.2123 -14.1130 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.1988 -17.0387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2122 -17.6238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1853 -17.6238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.1718 -17.0387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1583 -17.6239 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.1448 -17.0387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0226 -15.8755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.8784 -15.6322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2907 -14.6151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1218 -14.6151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5422 -15.6314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1275 -16.6452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2935 -16.6452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0763 -17.5144 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.1718 -15.8685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 1 1 0
4 3 2 0
5 4 1 0
6 5 2 0
7 6 1 0
1 7 2 0
8 7 1 0
8 9 1 0
9 10 1 0
10 11 1 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
16 18 1 0
18 19 1 0
18 20 2 0
10 21 2 0
22 9 2 0
22 23 1 0
24 22 1 0
25 24 1 0
25 26 1 0
26 27 1 0
28 27 2 0
29 28 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
34 33 1 0
34 29 2 0
35 34 1 0
35 27 1 0
36 25 2 0
36 8 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 502.92Molecular Weight (Monoisotopic): 502.1156AlogP: 4.60#Rotatable Bonds: 5Polar Surface Area: 141.74Molecular Species: ACIDHBA: 8HBD: 4#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.70CX Basic pKa: 5.46CX LogP: 2.76CX LogD: 0.08Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.31Np Likeness Score: -1.14
References 1. (2021) Galactokinase inhibitors,